FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

CHMP Recommends Approval of Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Home
/
insight
/
details

Proteomics in the Quest for Biomarkers

NextEdge Admin

12 Oct 2023

3 min 36 sec

Proteomics is a branch of molecular biology that involves the study of the entire set of proteins produced by an organism, system, or biological process. It is a powerful and comprehensive approach to understand the structure, function, and interactions of proteins within a biological system. Proteomics plays a crucial role in various areas of research, including biomarker discovery. Biomarkers are measurable indicators of biological processes, conditions, or diseases. They can be found in various biological materials such as blood, urine, tissues, or other body fluids. Biomarker discovery is a key aspect of medical research, as it enables the identification of markers that can be used for disease diagnosis, prognosis, and monitoring, as well as for understanding the underlying mechanisms of diseases.

Here’s how proteomics contributes to biomarker discovery:

Identification of Candidate Biomarkers: Proteomics allows researchers to analyze the entire proteome of a biological sample, enabling the identification of potential biomarkers associated with a particular disease or condition.
Differential Proteomics: By comparing the protein expression profiles of healthy and diseased tissues, researchers can identify proteins that are upregulated or downregulated in specific conditions. These differentially expressed proteins may serve as biomarker candidates.
Mass Spectrometry: Mass spectrometry is a key technology in proteomics that allows the identification and quantification of proteins. It helps in the detection of specific protein biomarkers and provides information about their structure and modifications.
Protein Profiling: Proteomics techniques, such as two-dimensional gel electrophoresis and liquid chromatography-mass spectrometry (LC-MS), enable the profiling of proteins in complex biological samples. This can reveal patterns of protein expression that are indicative of certain diseases.
Post-translational Modifications (PTMs): Proteomics can identify and characterize posttranslational modifications of proteins, such as phosphorylation or glycosylation. These modifications can influence the function of proteins and may serve as biomarkers for specific conditions.
Protein Interaction Networks: Understanding the interactions between proteins is crucial for deciphering the complexity of biological systems. Proteomics can provide insights into protein protein interactions, helping identify key players in disease pathways.
Validation and Verification: Once potential biomarkers are identified through proteomic analysis, further validation and verification studies are conducted to confirm their relevance and reliability as biomarkers.